Amy W Hudson (Amy Hudson)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Endoplasmic Reticulum Stress

Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

Journal of virology

Science advances

Journal of immunology (Baltimore, Md. : 1950)

Life science alliance

This page only lists publications with an associated author ORCID identifier.

Publications

Christine L Schneider, Melissa L Whyte, Sheryl L Konrad, Amy W Hudson
Characterization of the HHV-6B U20 Immunoevasin. Journal of virology 97 (2) (2023)
Christine L Schneider, Melissa L Whyte, Sheryl L Konrad, Amy W Hudson
Characterization of the HHV-6B U20 Immunoevasin. Journal of virology 97 (2) (2023)
Christine L Schneider, Melissa L Whyte, Sheryl L Konrad, Amy W Hudson
Characterization of the HHV-6B U20 Immunoevasin. Journal of virology 97 (2) (2023)
Christine L Schneider, Melissa L Whyte, Sheryl L Konrad, Amy W Hudson
Characterization of the HHV-6B U20 Immunoevasin. Journal of virology (2023)
Christine L Schneider, Melissa L Whyte, Sheryl L Konrad, Amy W Hudson
Characterization of the HHV-6B U20 Immunoevasin. Journal of virology 97 (2) (2023)
Nicholas J Hess, David P Turicek, Jeremiah M Riendeau, Sean J McIlwain, Emmanuel Contreras Guzman, Kalyan Nadiminti, Amy W Hudson, Natalie S Callander, Melissa C Skala, Jenny E Gumperz, Peiman Hematti, Christian M Capitini
Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology. Science advances 9 (12) (2023)
Christine L Schneider, Melissa L Whyte, Sheryl L Konrad, Amy W Hudson
Characterization of the HHV-6B U20 Immunoevasin. Journal of virology 97 (2) (2023)
Nicholas J Hess, Nikhila S Bharadwaj, Elizabeth A Bobeck, Courtney E McDougal, Shidong Ma, John-Demian Sauer, Amy W Hudson, Jenny E Gumperz
iNKT cells coordinate immune pathways to enable engraftment in nonconditioned hosts. Life science alliance 4 (7) (2021)
Nicholas J Hess, Amy W Hudson, Peiman Hematti, Jenny E Gumperz
Early T Cell Activation Metrics Predict Graft-versus-Host Disease in a Humanized Mouse Model of Hematopoietic Stem Cell Transplantation. Journal of immunology (Baltimore, Md. : 1950) 205 (1) (2020)